Evaluation And Management Of Perioperative Cirrhosis

Evaluation And Management Of Perioperative Cirrhosis is organized by Society of Hospital Medicine (SHM).

Dates:
Release Date: Dec 12, 2019
Expiration Date: Dec 11, 2022

Accreditation:
The Society of Hospital Medicine designates this activity for a maximum of 2 AMA PRA Category 1 CreditsTM / 2.00 ABIM MOC Self Evaluation Points

Overview
Patients with liver disease who undergo surgery, whether elective or emergent, are at increased risk for complications. In patients with cirrhosis, perioperative morbidity and mortality vary depending on the type of surgery. An accurate assessment of the presence and severity of acute or chronic liver disease is necessary to plan for perioperative management. Although most patients should continue liver-directed therapies, adjustments in medications may be necessary for certain liver diseases. This module outlines the risk associated with different types of surgery and identifies the elements of the preoperative evaluation for patients with cirrhosis. The influences on morbidity and mortality and formulation of pre- and postoperative care plans are reviewed as well.

Learning Objectives:
After completing the module, the participant should be able to:
• Evaluate whether liver disease severity influences perioperative morbidity and mortality.
• Outline the risk associated with different types of surgery in patients with cirrhosis.
• Identify the elements of the preoperative evaluation for a patient with cirrhosis including how to manage medications on the day of surgery.
• Formulate a perioperative care plan for the patient with cirrhosis based on the underlying severity of disease including how to manage medications.